
EHA2023	Not Applicable	Pre B-cell acute lymphoblastic leukemia	21	Two-dose regimen of inotuzumab	aytzyyetpu(hmbocogoaf) = Grade 1-3 hepatotoxicity occurred in 5 cases (23.8%) mzlkendefq (ozjcsygpbx )	-	08 Jun 2023
EHA2023	Phase 2	Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia	83	Mini-Hyper-CVD-Inotuzumab	fvmztkmqbt(avckkwgxdt) = cazoypkhzc shydtfyvoc (vuztbebjkj ) View more	-	08 Jun 2023
EHA2023	Phase 2		83	Mini-Hyper-CVD-Inotuzumab+Blinatumomab	fbeqnybfay(asfughmwxf) = bpyplnchdt imywdmzyip (exkyabuhtd ) View more	-	08 Jun 2023

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis